Ascendis Pharma AS (A71) — Capital Reinvestment Ratio
Ascendis Pharma AS (A71) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (€73.40 Million) in capital expenditures (€3.39 Million). See A71 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ascendis Pharma AS Capital Reinvestment Ratio (2025–2025)
This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 1 annual periods. Check A71 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ascendis Pharma AS (2025–2025)
Year-by-year Capital Reinvestment Ratio for Ascendis Pharma AS from 2025 to 2025. For live market cap and broader valuation context, see A71 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €53.90 Million | €8.48 Million | — |